Abstract: A pillar-shaped honeycomb structure includes an outer peripheral side wall, and a plurality of partition walls partitioning a plurality of cells, wherein an average pore diameter of the partition walls measured by a mercury intrusion method specified in JIS R1655: 2003 is 3 to 10 ?m, and when a cross-section of the plurality of partition walls is observed with an X-ray microscope and a porosity (%) is measured in a thickness direction from one surface to the other surface of each partition wall, assuming PAVE is an average porosity of each partition wall, P1 MIN is a minimum porosity from the one surface to a thickness of 5% of the partition wall, and P2MIN is a minimum porosity from the other surface to a thickness of 5% of the partition wall, 40% PAVE ?70%, and {(P1 MIN+P2MIN)/2} /PAVE ?0.9 are satisfied.

Abstract: A pillar-shaped honeycomb structure including an outer peripheral side wall, and a plurality of partition walls disposed on an inner peripheral side of the outer peripheral side wall, the plurality of partition walls partitioning a plurality of cells forming flow paths from a first end surface to a second end surface, wherein an average pore diameter of the partition walls measured by a mercury porosimeter is 10 ?m or less, and when a cross section of the plurality of partition walls is observed with an X-ray microscope and porosities (%) of each partition wall is measured in a thickness direction from one surface to the other surface of each partition wall, an average porosity of each partition wall is 40 to 70%, and a difference between a maximum value and a minimum value of the porosity of each partition wall is 11% or less.

Abstract: The problem that differences among lots in components and amounts of growth factors and the like in platelet-rich plasmas derived from an autologous plasma and the freeze-dried preparations thereof are large, and the effects of the lots are not kept constant is solved. Specifically, a freeze-dried preparation comprising megakaryocytes and platelets induced to differentiate from stem cells, a pharmaceutical composition comprising the freeze-dried preparation, and the like are provided.

Abstract: A polyurethane top coating and a porous, polyurethane interposing layer are formed on a release carrier sheet. Split leather hide is bonded onto the porous layer with a compatible adhesive and the release carrier sheet is stripped from the top coat. The resultant laminate has the appearance and other properties of top-grain leather. The interposing porous layer functions as a cushion and prevents uneven deformation of top coat when the laminate is folded or stretched.

Abstract: Artificial leather is produced by applying a dope comprising urethane prepolymers containing terminal isocyanate groups, an amine catalyst and a foam stabilizer onto a releasing carrier sheet, exposing the resulting coating layer to a moisture-containing gas under controlled conditions, laminating the coating layer onto a backing material and stripping off the releasing carrier sheet. The resulting artificial leather has a cellular structure of polyurethane microfoam in adhesion with the backing material and an adhesion strength of 100 to 10,000 g/cm of width.